Application of self-assembly peptides targeting the mitochondria as a novel treatment for sorafenib-resistant hepatocellular carcinoma cells

Currently, there is no appropriate treatment option for patients with sorafenib-resistant hepatocellular carcinoma (HCC). Meanwhile, pronounced anticancer activities of newly-developed mitochondria-accumulating self-assembly peptides (Mito-FF) have been demonstrated. This study intended to determine...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Main Authors: Hong, Tae Ho, Jeena, M. T., Kim, Ok-Hee, Kim, Kee-Hwan, Choi, Ho Joong, Lee, Kyung Hee, Hong, Ha-Eun, Ryu, Ja-Hyoung, Kim, Say-June
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7806888/
https://ncbi.nlm.nih.gov/pubmed/33441650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-79536-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares